4-Bromo-N-{3-[5-(trifluoromethyl)pyridin-2-yl]phenyl}benzene-1-sulfonamide

Catalog No. :
ACKPWP953
CAS No. :
1092346-17-2
Molecular Formula :
C18H12BrF3N2O2S
Molecular Weight :
457.27

IUPAC Name:4-bromo-N-(3-(5-(trifluoromethyl)pyridin-2-yl)phenyl)benzenesulfonamide

4-Bromo-N-{3-[5-(trifluoromethyl)pyridin-2-yl]phenyl}benzene-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-N-{3-[5-(trifluoromethyl)pyridin-2-yl]phenyl}benzene-1-sulfonamide
IUPAC Name4-bromo-N-(3-(5-(trifluoromethyl)pyridin-2-yl)phenyl)benzenesulfonamide
MDL No.MFCD11501700
Molecular FormulaC18H12BrF3N2O2S
Molecular Weight457.27
SMILESO=S(C1=CC=C(Br)C=C1)(NC2=CC=CC(C3=NC=C(C(F)(F)F)C=C3)=C2)=O
InChI KeyXTVSPTQIPXBXQC-UHFFFAOYSA-N
Synonym4-bromo-N-{3-[5-(trifluoromethyl)pyridin-2-yl]phenyl}benzene-1-sulfonamide;Benzenesulfonamide, 4-bromo-N-[3-[5-(trifluoromethyl)-2-pyridinyl]phenyl]-
CAS No.1092346-17-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKPWP953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKPWP953 route product structure diagram
    ACKPWP9531092346-17-2
Inquiry

2. ACKPWP953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFRZX973 route compound structure diagram
    ACFRZX97352334-81-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKPWP953 route product structure diagram
    ACKPWP9531092346-17-2
Inquiry

Comments (0)